Vanguard Group Inc. increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 0.5% in the third quarter, bringing its total holdings to $8.84 billion, representing 9.63% of the company’s stock. Other institutional investors also adjusted their positions. Analyst ratings for BMY are mixed, with an average “Hold” rating and a target price of $59.20.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vanguard Group Inc. Has $8.84 Billion Stock Holdings in Bristol Myers Squibb Company $BMY
Vanguard Group Inc. increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 0.5% in the third quarter, bringing its total holdings to $8.84 billion, representing 9.63% of the company’s stock. Other institutional investors also adjusted their positions. Analyst ratings for BMY are mixed, with an average “Hold” rating and a target price of $59.20.